StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) stock

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.70+0.09 (+3.45%)

Close on Nov 18, 2026Market cap $24.34MP/E –Yield –

Nasus Pharma shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 8M, up 14.0% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20258M+14.0%
FY2024Dec 31, 20247M-0.4%
FY2023Dec 31, 20237M–

More Nasus Pharma figures

See a number that looks wrong?